08/27/2026
is becoming part of how modern medicine moves forward, from discovering new molecules to designing clinical trials and bringing treatments to patients.
In the latest episode of the AI Proving Ground Podcast, Dr. Thomas Fuchs, Chief AI Officer at Eli Lilly and Company, joins WWT for a wide-ranging conversation about what that transformation looks like inside one of the world’s leading pharmaceutical companies.
He shares how Lilly is applying AI across research and development, where the technology is already changing the pace and possibilities of the work, and why human expertise remains central as these capabilities advance.
It’s a fascinating look at AI through the lens of an industry where innovation can have a profound human impact.
Watch the full conversation: http://ms.spr.ly/6182aPA7w